The Amrit Campaign:
Natural Antidote to Chemotherapy’s Toxic Side-Effects

Summary:
To publicize the benefits of MAPI’s super-antioxidant “Amrit” formula (MAK4) for patients undergoing chemotherapy, we highlighted research conducted by Hari Sharma, M.D., Professor Emeritus and former Director of Cancer Prevention and Natural Products Research at the Ohio State University College of Medicine. Dr. Sharma’s study showed Amrit to be a promising adjuvant to chemotherapy—reducing symptoms of nausea and vomiting (22% less than controls), anorexia (26% less), and improving patients’ ability to tolerate treatments (17.5% more). “Amrit helps patients complete their course of chemotherapy,” explained Dr. Sharma, who had researched the antioxidant effects of the formula for over 10 years. “Amrit is the broadest spectrum antioxidant combination I have seen.” His research found Amrit to be 1000 times more powerful in antioxidant properties than vitamin C, E and even the pharmaceutical probucol.

Strategy:
To mitigate media bias against a CAM approach, we focused on Amrit's proven ability to improve patient compliance during chemotherapy.

We set up a test tour targeting Wellness Centers and cancer support groups in Ohio, where the research had been conducted. Dr. Sharma presented his findings along with renowned Northern Kentucky plastic and reconstructive surgeon, Christine Horner-Taylor, M.D. A number of cancer patients agreed to provide testimonials at these presentations and also conduct media interviews. Based on our success in Ohio, we expanded the tour to other cities across the country.